Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(αR,βS)-rel-Bedaquiline-d6 is the labelled analogue of (αR,βS)-rel-Bedaquiline (B119555), a promising diarylquinoline candidate in clinical development for the treatment of tuberculosis. (αR,βS)-rel-Bedaquiline inhibits mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis.
?您的位置：
